NRT Smoking Cessation Aids in South Korea

Publication Date	January 2009
Publisher	Euromonitor
Product Type	Report
Pages	30
ISBN Number	not applicable
Product Code	EUR00418

Buy this product or for assistance call +44 20 7060 7474

PDF £560.00$932 | €627

FAX Order above formats by FAX

Summary

Euromonitor International's NRT Smoking Cessation Aids in South Korea report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2002-2007), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2012 illustrate how the market is set to change.

Product coverage: NRT gum, NRT patches, NRT inhalators, other

Data coverage: market sizes (historic and forecasts), company shares, brand shares

Why buy this report?

Get a detailed picture of the smoking cessation aids industry
Pinpoint growth sectors and trends and identify factors driving change
Understand the competitive environment, the market's major players and leading brands
Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning

Content

Nrt Smoking Cessation Aids in South Korea
- Euromonitor International
- January 2009
- List of Contents and Tables
- Executive Summary
- OTC Continues Downward Trend in Contrast To Strong Rx Growth
- Business Diversification by Pharmaceutical Manufacturers
- Distribution All Set for Change
- Continued Downward Trend for Child-specific OTC Products
- Reduced Marketing Spend on OTC Products
- Key Trends and Developments
- OTC Continues Poor Performance As Rx Market Grows Strongly
- Diversification by Pharmaceutical Manufacturers To Survive
- Distributional Map May Soon Change
- Downward Trend in Child-specific OTC Products
- Manufacturers Reduce Marketing Spend for OTC Products
- Market Indicators
  - Table 1 Consumer Expenditure on Health Goods and Medical Services 2002-2007
  - Table 2 Life Expectancy at Birth 2002-2007
- Market Data
  - Table 3 Sales of OTC Healthcare by Sector: Value 2002-2007
  - Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2002-2007
  - Table 5 OTC Healthcare Company Shares by Value 2003-2007
  - Table 6 OTC Healthcare Brand Shares by Value 2004-2007
  - Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2002-2007
  - Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2007
  - Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2007-2012
  - Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2007-2012
- Appendix
- OTC Registration and Classification
- Vitamins and Dietary Supplements Registration and Classification
- Generics
- Switches
- Definitions
Summary 1 Research Sources
- Daewoong Pharmaceutical Co Ltd
- Strategic Direction
- Key Facts
Summary 2 Daewoong Pharmaceutical Co Ltd: Key Facts
Summary 3 Daewoong Pharmaceutical Co Ltd: Operational Indicators
- Company Background
- Production
Summary 4 Daewoong Pharmaceutical Co Ltd: Production Statistics 2007
- Competitive Positioning
Summary 5 Daewoong Pharmaceutical Co Ltd: Competitive Position 2007
- Dong Wha Pharmaceutical Industrial Co Ltd
- Strategic Direction
- Key Facts
Summary 6 Dong Wha Pharmaceutical Industrial Co Ltd: Key Facts
Summary 7 Dong Wha Pharmaceutical Industrial Co Ltd: Operational Indicators
- Company Background
- Production
Summary 8 Dong Wha Pharmaceutical Industrial Co Ltd: Production Statistics 2007
- Competitive Positioning
Summary 9 Dong Wha Pharmaceutical Industrial Co Ltd: Competitive Position 2007
- Dong-a Pharmaceutical Co Ltd
- Strategic Direction
- Key Facts
Summary 10 Dong-A Pharmaceutical Co Ltd: Key Facts
Summary 11 Dong-A Pharmaceutical Co Ltd: Operational Indicators
- Company Background
- Production
Summary 12 Dong-A Pharmaceutical Co Ltd: Production Statistics 2007
- Competitive Positioning
Summary 13 Dong-A Pharmaceutical Co Ltd: Competitive Position 2007
- Kwang Dong Pharm Co Ltd
- Strategic Direction
- Key Facts
Summary 14 Kwang Dong Pharm Co Ltd: Key Facts
Summary 15 Kwang Dong Pharm Co Ltd: Operational Indicators
- Company Background
- Production
Summary 16 Kwang Dong Pharm Co Ltd: Production Statistics 2007
- Competitive Positioning
Summary 17 Kwang Dong Pharm Co Ltd: Competitive Position 2007
- Sk Chemicals Co Ltd
- Strategic Direction
- Key Facts
Summary 18 SK Chemicals Co Ltd: Key Facts
Summary 19 SK Chemicals Co Ltd: Operational Indicators
- Company Background
- Production
Summary 20 SK Chemicals Co Ltd: Production Statistics 2007
- Competitive Positioning
Summary 21 SK Chemicals Co Ltd: Competitive Position 2007
- Headlines
- Trends
- Switches
- Competitive Landscape
- Prospects
- Sector Indicators
  - Table 11 Number of Smokers by Gender 2002-2007
- Sector Data
  - Table 12 Sales of Smoking Cessation Aids by Subsector: Value 2002-2007
  - Table 13 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2002-2007
  - Table 14 NRT Gum Flavours 2006-2007
  - Table 15 Smoking Cessation Aids Company Shares by Value 2003-2007
  - Table 16 Smoking Cessation Aids Brand Shares by Value 2004-2007
  - Table 17 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2007-2012
  - Table 18 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2007-2012